Skip to Content

Belamaf shows deeper, longer-lasting myeloma response

Belamaf monotherapy shows a deeper and more durable response and longer median PFS vs pomalidomide and low-dose dexamethasone.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top